home > events calendar > more about event

2019 PDA Annual Meeting

PDA Annual Meeting - USA

11-13 March 2019
Marriot Marquis San Diego, CA

Centered on the theme of Solving Manufacturing and Supply Challenges for Current and Future Medicinal Products, the 2019 PDA Annual Meeting is the premier venue for learning, benchmarking, and exploring the latest thinking with respect to innovation and continuous improvement in bio/pharmaceuticals.

Taking place over two and a half days in sunny San Diego, CA, this event has an agenda packed with the latest information on new technologies and therapies important to both small molecule and biopharmaceutical industries.

PDA is pleased to announce the following confirmed speakers:

  • Mike Thien, PhD, Senior Vice President of Operations, Manufacturing Systems Design and Commercialization, Merck & Co., Inc.
  • Nitin Rathore, PhD, Director of Core Technologies,Amgen Inc.
  • Gilad Langer, PhD, Vice President of Business Development,Bigfinite

Experts will share their insights during five plenary sessions, including:

  • From Bench to Bedside
  • Navigating the Global Regulatory Landscape
  • Accelerating Pharmaceutical Innovation
  • Bridging Current Technology with the Future of Medicine
  • Disaster Recovery/Business Continuity

Here’s what else you can look forward to at the Meeting:

  • Concurrent tracks on key industry topics, including innovative manufacturing strategies, disruptive technologies, supply chain complexity, and more.
  • Interest Group meetings offering in-depth discussion in key areas of interest
  • A packed Exhibit Hall showcasing the latest innovative technologies
  • Networking events, including activities specifically geared toward young professionals

Attend this flagship PDA meeting to investigate unique challenges, analyze current capabilities, and envision the possibilities of bio/pharmaceutical manufacturing!

Immediately following the Conference, on March 13-14, PDA will be hosting the 2019 PDA Practical Application of Sterile Manufacturing Workshop, exploring how companies are using innovative technologies to improve the quality, speed, and reliability of aseptic processing to ensure continued success in the production of sterile products.

Get the insider perspective on how the sterile manufacturing field is incorporating innovations in barrier technologies, implementing robotics, adopting rapid test methods, and tackling the challenges personalized medicine presents to conventional technologies.

On March 15, PDA will offer seven training courses on a variety of related topics as part of the 2019 Annual Meeting Training Course Series. Choose from the following training course options:

·        Preparing for Regulatory Inspections for the FDA and EMA

·        The Impact of CGMPs on Biomanufacturing Facility Design and Operation

·        Optimizing Human Factors to Improve Data Integrity

·        Clean Room Investigations

·        A Critical Thinking Approach to Improving Aseptic Process Manufacturing

·        Change Management – A Practical Workshop

·        Drug Device and Combination Product Risk Management and Safety Assurance Cases

Join PDA in San Diego for a full week of learning and networking opportunities to advance your knowledge and your career!

Visit and to learn more!
phone (301) 656-5900 ext. 115
email Marriot Marquis San Diego, CA
Print this page
Send to a friend
Industry Events

Clinical Operations in Oncology Trials West Coast

21-22 April 2020, Hilton San Francisco Airport Bayfront

Clinical Operations in Oncology Trials West Coast will be returning this April for another 2 day event full of thought-provoking presentations, discussions and roundtables. This years' conference highlights include the high-level, interactive immuno-oncology discussion panel where specialists from Shasta Bio Ventures, Abbvie and BeiGene shared their top tips on how to run successful and impactful immuno-oncology studies.
More info >>

White Papers

What is process characterization?


Process characterization is an essential step in the commercialization of a new (biological) drug. For drug product commercialization, manufacturers must validate the drug’s manufacturing process. This ensures that the manufacturing process delivers consistently a quality product and that the patient is not at risk.
More info >>

News and Press Releases

Signant Health Enhances Audit Trail Reporting Capabilities in TrialMax® to Improve eCOA Data Integrity Monitoring

PHILADELPHIA, PA – 29th January, 2020: Signant Health has announced new audit trail reviewing and reporting functionality today for its electronic clinical outcome assessment (eCOA) and remote sensor platform, TrialMax®.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement